47
https://pubmed.ncbi.nlm.nih.gov/38115234
In soft tissue sarcoma, mutation profiles can help predict drug response to second-line chemotherapy more effectively than histology.
https://pubmed.ncbi.nlm.nih.gov/38115234
In soft tissue sarcoma, mutation profiles can help predict drug response to second-line chemotherapy more effectively than histology.